2024 Q3 Form 10-Q Financial Statement

#000121390024095882 Filed on November 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$58.40K
YoY Change -3.27%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $14.48K
YoY Change 2.46%
Pretax Income -$43.92K
YoY Change -5.02%
Income Tax $1.640K
% Of Pretax Income
Net Earnings -$45.56K
YoY Change -32.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.130M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.150M
YoY Change -6.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $195.3K
YoY Change -63.49%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $677.3K
YoY Change 21.52%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $677.3K
Total Long-Term Liabilities
Total Liabilities $680.3K
YoY Change -3.69%
SHAREHOLDERS EQUITY
Retained Earnings -$563.1K
YoY Change 10.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $469.8K
YoY Change
Total Liabilities & Shareholders Equity $1.150M
YoY Change -6.37%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$45.56K
YoY Change -32.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39534
dei Entity Registrant Name
EntityRegistrantName
PMV Consumer Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-5174573
dei Entity Address Address Line1
EntityAddressAddressLine1
249 Royal Palm Way
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 503
dei Entity Address City Or Town
EntityAddressCityOrTown
Palm Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33480
dei City Area Code
CityAreaCode
(561)
dei Local Phone Number
LocalPhoneNumber
318-3766
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1130295 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1072630 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19789 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
129474 usd
CY2024Q3 us-gaap Assets
Assets
1150084 usd
CY2023Q4 us-gaap Assets
Assets
1202104 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
195278 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
175745 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
10259 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
677278 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
578004 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2980 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2980 usd
CY2024Q3 us-gaap Liabilities
Liabilities
680258 usd
CY2023Q4 us-gaap Liabilities
Liabilities
580984 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
460000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
460000 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1032917 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1032917 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-563101 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-411807 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
469826 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
621120 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1150084 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1202104 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50395 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57670 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
148092 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
201842 usd
CY2024Q3 pmvcd Franchise Tax Expense
FranchiseTaxExpense
8000 usd
CY2023Q3 pmvcd Franchise Tax Expense
FranchiseTaxExpense
2700 usd
pmvcd Franchise Tax Expense
FranchiseTaxExpense
23286 usd
pmvcd Franchise Tax Expense
FranchiseTaxExpense
10200 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58395 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-60370 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-171378 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-212042 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
14480 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
14132 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
42075 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
36981 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14480 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
14132 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
42075 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
36981 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43915 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46238 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-129303 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-175061 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1640 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21024 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21991 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32226 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-45555 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-67262 usd
us-gaap Net Income Loss
NetIncomeLoss
-151294 usd
us-gaap Net Income Loss
NetIncomeLoss
-207287 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
621120 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-77383 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
543737 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-28356 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
515381 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-45555 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
469826 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
729261 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-98590 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
630671 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-41435 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
589236 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-67262 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
521974 usd
us-gaap Net Income Loss
NetIncomeLoss
-151294 usd
us-gaap Net Income Loss
NetIncomeLoss
-207287 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-42424 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-109685 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46989 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-10259 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-7774 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
19533 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14666 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
90000 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
90000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57665 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50314 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
57665 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-50314 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1072630 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1149157 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1130295 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1098843 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
34000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40000 usd
CY2023Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
100000000 shares
CY2024Q3 pmvcd Ownership Percentage
OwnershipPercentage
0.20 pure
CY2024Q3 us-gaap Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
154874303 usd
CY2024Q3 pmvcd Redemption Common Stock Price Per Share
RedemptionCommonStockPricePerShare
10.02
us-gaap Interest Expense Trust Preferred Securities
InterestExpenseTrustPreferredSecurities
340393 usd
pmvcd Aggregate Amount Of Remaining Trust Account
AggregateAmountOfRemainingTrustAccount
20511170 usd
CY2022Q4 pmvcd Redeemed Of Cash
RedeemedOfCash
42424 usd
CY2023Q1 pmvcd Aggregate Purchase Price
AggregatePurchasePrice
42000 shares
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In light of the Class C Conversion, and in order to simplify and better reflect the purpose, capital structure, governance and organizational policies and procedures of the Company, the Board of Directors of the Company (the “Board”) recommended, and the stockholders approved on September 29, 2023, various amendments to the Charter, as well as a reverse stock split of all outstanding shares of Class B convertible common stock and Class C common stock at a ratio of 43.792-to-1 (the “Reverse Stock Split”).
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred, or a lack of access to such funds, could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock, resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering.
CY2020Q3 us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
656250 shares
CY2020Q3 pmvcd Shares Conversion Ration Percentage
SharesConversionRationPercentage
0.20 pure
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42000 usd
CY2020Q3 us-gaap Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
10000 usd
CY2024Q3 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
30000 usd
CY2023Q3 us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
30000 usd
us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
90000 usd
us-gaap Payment For Administrative Fees
PaymentForAdministrativeFees
90000 usd
CY2024Q3 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
1
pmvcd Underwriting Deferred Fee
UnderwritingDeferredFee
0.35
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
6125000 usd
CY2022Q3 pmvcd Deferred Underwriting Commission
DeferredUnderwritingCommission
4593750 usd
CY2022Q4 pmvcd Forfeiture Remaining Deferred Underwriting Fee
ForfeitureRemainingDeferredUnderwritingFee
1531250 usd
CY2022 pmvcd Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
6125000 usd
CY2022Q4 pmvcd Forgiveness Of The Deferred Underwriting Fee Allocated To Public Shares
ForgivenessOfTheDeferredUnderwritingFeeAllocatedToPublicShares
5815688 usd
CY2022 pmvcd Gain From Extinguishment Of Liability Allocated To Warrant Liabilities
GainFromExtinguishmentOfLiabilityAllocatedToWarrantLiabilities
309312 usd
us-gaap Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
●in whole and not in part;   ● at a price of $0.01 per warrant;   ● upon not less than 30 days’ prior written notice of redemption;   ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and   ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants.
pmvcd Warrant Price
WarrantPrice
0.01
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
18
CY2024Q3 pmvcd Shares Outstanding Percentage
SharesOutstandingPercentage
1 pure
CY2023Q4 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
100000 shares
CY2024Q3 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
432880 usd
CY2023Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
401781 usd
CY2024Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
432880 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
401781 usd
CY2024Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
432880 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
401781 usd
CY2024Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1280 usd
CY2023Q3 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8077 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
19400 usd
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8627 usd
CY2024Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-10583 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-31099 usd
CY2024Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
360 usd
CY2023Q3 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
12947 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2591 usd
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
23599 usd
CY2024Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10583 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
31099 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1640 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21024 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21991 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32226 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.02 pure
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.135 pure
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.12 pure
us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.259 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.241 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.17 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.184 pure
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
CY2024Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
usd
CY2024Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q3 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001807765

Files In Submission

Name View Source Status
0001213900-24-095882-index-headers.html Edgar Link pending
0001213900-24-095882-index.html Edgar Link pending
0001213900-24-095882.txt Edgar Link pending
0001213900-24-095882-xbrl.zip Edgar Link pending
ea0216996-10q_pmvcon.htm Edgar Link pending
ea021699601ex31-1_pmvcon.htm Edgar Link pending
ea021699601ex31-2_pmvcon.htm Edgar Link pending
ea021699601ex31-3_pmvcon.htm Edgar Link pending
ea021699601ex32-1_pmvcon.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pmvcd-20240930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pmvcd-20240930_cal.xml Edgar Link unprocessable
pmvcd-20240930_def.xml Edgar Link unprocessable
ea0216996-10q_pmvcon_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pmvcd-20240930_lab.xml Edgar Link unprocessable
pmvcd-20240930_pre.xml Edgar Link unprocessable